sacituzumab govitecan,Pembrolizumab,Avelumab,Zimberelimab,Domvanalimab
Gilead Sciences,Merck,Pfizer,Arcus Biosciences,Otsuka
['sacituzumab', 'urothelial', 'urothelial carcinoma', 'sacitu, govi']
sacituzumab govitecan elicits responses in platinum-ineligible metastatic urothelial carcinoma #medpub #oncotwitter #meded #oncology 
#Oncology news from major publishers consolidated for a more streamlined industry news experience.🎗🗞